Article
Physician and Patient Satisfaction with Poly(ADP-ribose) Polymerase Inhibitors (PARPi) versus Chemotherapy in Adult Patients with Germline BRCA1/2 Mutated (gBRCA1/2mut) HER2- advanced Breast Cancer (ABC): Results from a Multi-country Real-world (RW) Study
Cancer Research / San Antonio Breast Cancer Symposium
(2021)
Abstract
M. Lux; A. Niyazov; K. Lewis; J. Pike; A. Rider; B. Arondekar
Disciplines
Publication Date
February 15, 2021
Citation Information
Reshma Mahtani. "Physician and Patient Satisfaction with Poly(ADP-ribose) Polymerase Inhibitors (PARPi) versus Chemotherapy in Adult Patients with Germline BRCA1/2 Mutated (gBRCA1/2mut) HER2- advanced Breast Cancer (ABC): Results from a Multi-country Real-world (RW) Study" Cancer Research / San Antonio Breast Cancer Symposium Vol. 81 Iss. 4 Supplement (2021) Available at: http://works.bepress.com/reshma-mahtani/49/